Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (11-20 of 573) with videos related to

Pageof 58
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approachDavid L Paterson
American Journal of Infection Control|July 4, 2006
Resistance in gram-negative bacteria: EnterobacteriaceaeDavid L Paterson
Expert Opinion on Investigational Drugs|March 6, 2024
Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trialsDavid L Paterson
The Medical Journal of Australia|March 19, 2013
Determining research priorities for clinician-initiated trials in infectious diseasesDavid L Paterson,
The American Journal of Medicine|June 1, 2006
Resistance in gram-negative bacteria: enterobacteriaceaeDavid L Paterson
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
The challenge of treating superbugsDavid L Paterson
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2002
Cryptococcus neoformans infectionDavid L Paterson, Nina Singh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Strategies for reduction in duration of antibiotic use in hospitalized patientsYoshiro Hayashi, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Has the time come for routine trimethoprim-sulfamethoxazole prophylaxis in patients taking biologic therapies?Marta Bodro, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
A step closer to extreme drug resistance (XDR) in gram-negative bacilliDavid L Paterson, Yohei Doi
Pageof 58

Showing results (11-20 of 573) with videos related to

Sort By:
Pageof 58
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approachDavid L Paterson
American Journal of Infection Control|July 4, 2006
Resistance in gram-negative bacteria: EnterobacteriaceaeDavid L Paterson
Expert Opinion on Investigational Drugs|March 6, 2024
Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trialsDavid L Paterson
The Medical Journal of Australia|March 19, 2013
Determining research priorities for clinician-initiated trials in infectious diseasesDavid L Paterson,
The American Journal of Medicine|June 1, 2006
Resistance in gram-negative bacteria: enterobacteriaceaeDavid L Paterson
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
The challenge of treating superbugsDavid L Paterson
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2002
Cryptococcus neoformans infectionDavid L Paterson, Nina Singh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Strategies for reduction in duration of antibiotic use in hospitalized patientsYoshiro Hayashi, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Has the time come for routine trimethoprim-sulfamethoxazole prophylaxis in patients taking biologic therapies?Marta Bodro, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
A step closer to extreme drug resistance (XDR) in gram-negative bacilliDavid L Paterson, Yohei Doi
Pageof 58